| MGLCX | MGLJX | MGLCX / MGLJX | |
| Total Expense Ratio | 1.93 | 1.93 | 100% |
| Annual Report Gross Expense Ratio | 1.94 | 1.94 | 100% |
| Fund Existence | 12 years | 12 years | - |
| Gain YTD | 9.456 | 9.455 | 100% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 1000 | 0 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 2.17B | 2.17B | 100% |
| Annual Yield % from dividends | 1.83 | 1.94 | 94% |
| Returns for 1 year | 11.73 | 11.72 | 100% |
| Returns for 3 years | 16.62 | 16.65 | 100% |
| Returns for 5 years | -12.91 | -12.93 | 100% |
| Returns for 10 years | 14.37 | 15.59 | 92% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| KOLD | 28.94 | 0.30 | +1.05% |
| ProShares UltraShort Bloomberg Natrl Gas | |||
| EAD | 6.44 | 0.05 | +0.78% |
| Allspring Income Opportunities Fund | |||
| FIDU | 98.67 | 0.62 | +0.63% |
| Fidelity MSCI Industrials ETF | |||
| BLUX | 32.79 | 0.03 | +0.08% |
| BLUEMONTE DYNAMIC TOTAL MARKET ETF | |||
| HELX | 41.45 | -0.28 | -0.67% |
| Franklin Genomic Advancements ETF | |||